A Study of Use of “PORT” Catheter in Patients with Cancer: A Single-Center Experience

Abstract

Background:Effective and reliable venous access is one of the cornerstones of modern medical therapy in oncology.Materials and methods:This is a prospective observational study, which collected data of patients who require “PORT” catheter insertion for any cancer, at a tertiary care oncology hospital in Ahmadabad, Gujarat, India, during a 2-year period.Aims and objectives:The main objective of this study was to study the various complications and outcomes related to “PORT” catheters.Results:“PORT” catheter was inserted in 100 patients and was most commonly used in solid malignancies (n = 86, 86%), followed by hematologic malignancies (n = 14, 14%). Among the solid malignancies, breast cancer (38, 38%) was the most common underlying disease, whereas among the hematologic malignancies, acute lymphoblastic leukemia (6, 6%) was the most common underlying disease for “PORT” catheter insertion. Chemotherapy was started on the first day of “PORT” catheter in 74% of patients in the “PORT” study group. The various complications developed in the “PORT” study group in the descending order are as follows: 4 patients (4%) developed early infection (⩽30 days after “PORT” placement), 4 (4%) late infection (⩾30 days after “PORT” placement), 4 (4%) bloodstream infection, 2 (2%) local skin infection at the “PORT” insertion site, 2 (2%) dislodgment of the “PORT” catheter, 2 (2%) fracture of the “PORT” catheter, and 1 recurrent pleural effusion. One patient (1%) developed thrombosis as the complication of “PORT” catheter insertion.Conclusions:The most disturbing aspect of treatment for a patient with cancer is multiple painful venipunctures made for administration of cytotoxic agents, antibiotics, blood products, and nutritional supplements. The focus of this prospective observational research is to study the various underlying diseases for which “PORT” catheter is needed in different solid and hematologic malignancies and the various complications and outcomes in pediatric and adult patients with cancer.

Ambulatory management of pre- and extensively drug resistant tuberculosis patients with imipenem delivered through port-a-cath: A mixed methods study on treatment outcomes and challenges

“…However, no severe cardiac event especially arrhythmias were reported. Port-a-cath related complications were relatively common and more frequent than previously reported among cohorts of patients on chemotherapy [9,[23][24][25][26][27]. High rates of port-a-cath infections may be due to fact that most of the patients were residing in urban slums with poor infection control facilities.…”

Intraoperative ipsilateral subclavian port catheter implantation in resectable breast cancer patients: A novel, safe, and convenient clinical practice

“…PC is another classical route of administering chemotherapy, which provides deep venous access and allows for iterative perfusions, even for years. 11 The same pattern of complications (mainly thrombus events 12 and infections 13 ) is observed for both PC and PICC. Compared with PICC, PC has been proved to be associated with lower risk of major complications (infection, thrombus, etc.)…”

Port Kateter Uygulamaları: Kanserli Hastaların Deneyimlerine İlişkin Niteliksel Bir Çalışma

“…Port kateter, santral venlerin dışında organ veya bölgesel arterlere de yerleştirilmektedir (40). Literatüre göre, port kateterler en sık göğüs ön duvarına yerleştirilmekle birlikte karın, kasık veya kol antekübital alana da takılabilmektedir (41,42).…”